Oppenheimer Reaffirms Outperform Rating for Harmony Biosciences (NASDAQ:HRMY)
Oppenheimer reiterated their outperform rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $59.00 price target on the stock, up from their previous price target of $56.00. A number of other research firms also recently issued reports on HRMY. […]
More Stories
Eagle Point Credit Company Inc. Announces Dividend of $0.14 (NYSE:ECCC)
Eagle Point Credit Company Inc. (NYSE:ECCC – Get Free Report) declared a dividend on Saturday, January 11th,investing.com reports. Investors of...
Oracle Power (LON:ORCP) Shares Down 14.3% – What’s Next?
Oracle Power plc (LON:ORCP – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The company traded...
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Here’s What Happened
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report)’s stock price was up 50% during mid-day trading on Saturday ....
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Still a Buy?
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shares rose 50% on Saturday . The company traded as high...
PHX Minerals (NYSE:PHX) & EQT (NYSE:EQT) Financial Contrast
EQT (NYSE:EQT – Get Free Report) and PHX Minerals (NYSE:PHX – Get Free Report) are both oils/energy companies, but which...
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...